Lynx Therapeutics

Lynx Therapeutics is a biopharmaceutical company based in Troy, New York, dedicated to developing innovative pharmaceuticals and healthcare products. The company focuses on various therapeutic areas, including diabetes, oncology, respiratory, cardiology, and immunology. Lynx Therapeutics aims to provide life-changing advances for patients through science-driven innovation and a patient-centric approach. The company specializes in therapeutic development, with a pipeline that includes investigational drugs like KRX-211, a JAK3-targeted therapy for septic shock. Lynx Therapeutics also utilizes advanced biotechnology tools to enhance diagnostic accuracy and develop safer vaccines. Its commercial portfolio features a range of products and services designed to support disease management in both chronic and acute conditions. The company collaborates with healthcare providers and professionals to ensure effective delivery of its therapies.